Wed04232014

Last update 09:37:07 AM EST

Quest Diagnostics Completes Acquisition of Summit Health

Quest Diagnostics Completes Acquisition of Summit Health

Today, Quest Diagnostics announced that it has com...

FDA Warns Fibroid Procedure May Spread Hidden Cancers

FDA Warns Fibroid Procedure May Spread Hidden Cancers

In a safety communication issued on Thursday, the ...

The FDA Expands Approval of GSK and Genmab's Leukemia Drug

The FDA Expands Approval of GSK and Genmab's Leukemia Drug

GlaxoSmithKline (GSK) and Genmab A/S recently anno...

Galapagos and GlaxoSmithKline's Psoriasis Candidate Succeeds in Phase 2a Study

Galapagos and GlaxoSmithKline's Psoriasis Candidate Succeeds in Phase 2a Study

Today, Belgium-based biotechnology company Galapag...

BioRx Offers Health Outcomes Reporting Program for Primary Immune Deficiencies

BioRx Offers Health Outcomes Reporting Program for Primary Immune Deficiencies

National specialty pharmacy provider BioRx announced that it has expanded its Bi...

Sarepta to Initiate New Trials for its Duchenne Muscular Dystrophy Drug

Sarepta to Initiate New Trials for its Duchenne Muscular Dystrophy Drug

Today, Sarepta Therapeutics, Inc. announced plans to submit a New Drug Applicati...

FDA Approves Lilly's Gastric Cancer Drug

FDA Approves Lilly's Gastric Cancer Drug

On Monday, Eli Lilly and Company announced that its Cyramza (ramucirumab) has be...

Investigators Discover Biomarker Leading to Cancer Drug Resistance

Investigators Discover Biomarker Leading to Cancer Drug Resistance

Researchers have discovered a biomarker on the surface of drug-resistant tumors ...

FDA Warns Fibroid Procedure May Spread Hidden Cancers

FDA Warns Fibroid Procedure May Spread Hidden Cancers

In a safety communication issued on Thursday, the US Food and Drug Administratio...

The FDA Expands Approval of GSK and Genmab's Leukemia Drug

The FDA Expands Approval of GSK and Genmab's Leukemia Drug

GlaxoSmithKline (GSK) and Genmab A/S recently announced that the US Food and Dru...

Boehringer Ingelheim's Volasertib Receives Orphan Drug Designation from US and European Regulators

Boehringer Ingelheim's Volasertib Receives Orphan Drug Designation from US and European Regulators

Today, Boehringer Ingelheim announced that both the US Food and Drug Administrat...

Pfizer and AstraZeneca Partner with Cancer Research UK for Revolutionary Lung Cancer Trial

Pfizer and AstraZeneca Partner with Cancer Research UK for Revolutionary Lung Cancer Trial

Pfizer and AstraZeneca have joined the Cancer Research UK on the “National Lun...

Karyopharm Initiates Phase I Study of KPT-330 in Acute Myeloid Leukemia Patients

Karyopharm Initiates Phase I Study of KPT-330 in Acute Myeloid Leukemia Patients

Karyopharm Therapeutics Inc. recently announced the initiation of an early-stage...

Baxter's BAX 111 Meets Primary Endpoint in Phase III Von Willebrand Disease Trial

Baxter's BAX 111 Meets Primary Endpoint in Phase III Von Willebrand Disease Trial

A day before World Hemophilia Day, Baxter International Inc. announced that its ...

Galapagos and GlaxoSmithKline's Psoriasis Candidate Succeeds in Phase 2a Study

Galapagos and GlaxoSmithKline's Psoriasis Candidate Succeeds in Phase 2a Study

Today, Belgium-based biotechnology company Galapagos NV announced that UK-based ...

Novartis and GSK Enter A Three-Part Transaction

Novartis and GSK Enter A Three-Part Transaction

Today, Novartis AG and GlaxoSmithKline (GSK) announced a series of transactions ...

Biogen Enters License Agreement with Amunix for XTENylated Factor VIII

Biogen Enters License Agreement with Amunix for XTENylated Factor VIII

Biotechnology company Amunix Operating Inc. recently announced that Biogen Idec ...

Aastrom Biosciences to Acquire Sanofi's Cell Therapy and Regenerative Medicine Business

Aastrom Biosciences to Acquire Sanofi's Cell Therapy and Regenerative Medicine Business

Aastrom Biosciences Inc. announced that it has reached a definitive agreement to...

Quest Diagnostics Completes Acquisition of Summit Health

Quest Diagnostics Completes Acquisition of Summit Health

Today, Quest Diagnostics announced that it has completed the acquisition of Summ...

Epirus to Merge with Zalicus

Epirus to Merge with Zalicus

Epirus Biopharmaceuticals and Zalicus recently announced that they have entered ...

CPPA Launches New Practice Accreditation Program for Community Pharmacies

CPPA Launches New Practice Accreditation Program for Community Pharmacies

Today, The Center for Pharmacy Practice Accreditation (CPPA) announced the launc...

BioAlliance Pharma and Topotarget Merge to Create A Leading Orphan Oncology Company

BioAlliance Pharma and Topotarget Merge to Create A Leading Orphan Oncology Company

Today, BioAlliance Pharma SA and Topotarget A/S announced their intention to mer...